Myriad Genetics MYGN Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpensesOther.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Myriad Genetics's prepaid & other current?
- Myriad Genetics (MYGN) reported prepaid & other current of $9.7M in Q1 2026.
- How has Myriad Genetics's prepaid & other current changed year-over-year?
- Myriad Genetics's prepaid & other current increased by 340.9% year-over-year, from $2.2M to $9.7M.
- What is the long-term trend for Myriad Genetics's prepaid & other current?
- Over 2 years (2021 to 2025), Myriad Genetics's prepaid & other current has grown at a -82.7% compound annual growth rate (CAGR), from $6.7M to -$200K.
- What does prepaid & other current mean?
- Measures the net change in cash outflows for expenses paid in advance, such as insurance, subscriptions, or service contracts, before the related benefit is consumed. An increase in this metric represents a use of cash, while a decrease represents a source of cash as these assets are amortized. It serves as an indicator of short-term working capital management and operational spending patterns.